Construction at the CNY 58m ($8.5m) the project started in 2016. It produces slow-reacting diamine chain extenders, as well as various aromatic additives. The company already has 67kT/year capacity at the Nantong site and its headquarters in nearby Suzhou.
Xiangyuan currently has 20 products, five of which rolled out over the past year. It claims to have the broadest curative portfolio among its Chinese competitors. Exports to countries such as Germany, France and Japan are important to the firm.
It is China’s only maker of mid- to high-temperature curatives with performance comparable to international brands, said Zhou.
Last year, the company’s revenue jumped nearly a third to CNY 220m, and Zhou sees no problem keeping the momentum over the next few years.